JG
IONS icon

Jain Global’s Ionis Pharmaceuticals IONS Stock Holding History

Jain Global’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97M Sell
26,285
-329,974
-93% -$26M 0.01% 688
2025
Q4 		$28.2M Buy
356,259
+130,520
+58% +$9.83M 0.14% 150
2025
Q3 		$14.8M Buy
225,739
+218,544
+3,037% +$10.7M 0.07% 180
2025
Q2 		$284K Sell
7,195
-1,400
-16% -$45.8K ﹤0.01% 904
2025
Q1 		$259K Buy
+8,595
New +$281K ﹤0.01% 731

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jain Global's IONS Position: Q1 2026 in Review

Jain Global reduced its Ionis Pharmaceuticals (IONS) stake by 93% in Q1 2026, selling an estimated $26M and leaving 26,285 shares worth $1.97M. The position accounts for 0.01% of the portfolio, ranked #688.

Jain Global first reported a position in IONS in Q1 2025 and has held it in 5 quarters since. The position peaked at $28.2M in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Jain Global held 26,285 shares of Ionis Pharmaceuticals worth $1.97M as of Q1 2026.
  • Jain Global sold 329,974 Ionis Pharmaceuticals shares in Q1 2026, an estimated $26M.
  • Ionis Pharmaceuticals made up 0.01% of Jain Global's portfolio in Q1 2026, its #688 holding.
  • Jain Global first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Jain Global's Ionis Pharmaceuticals position peaked at $28.2M in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.